Verona Pharma plc (VRNA) Tops Q4 EPS by 1c

Verona Pharma plc (NASDAQ: VRNA) reported Q4 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03).

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Jaguar Health (JAGX) Tops Q2 EPS by 3647c
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance